Side-by-side financials for GDTC and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GDTC | NVS |
|---|---|---|
| Market cap | - | $293.70 B |
| US-listed rank | - | #46 |
| SEC filings | 120 | 947 |
Full pages: CytoMed Therapeutics Ltd and Novartis AG, or browse the full rankings.